Fubotv (FUBO) had the highest return between February 27, 2017 and April 5, 2017 by a US stock, returning 7,824.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Fubotv (FUBO) | 2/27/2017 - 4/5/2017 | 7,824.53% |
OLB (OLB) | 2/27/2017 - 4/5/2017 | 200% |
Sobr Safe (SOBR) | 2/27/2017 - 4/5/2017 | 150% |
Duos Technologies (DUOT) | 2/27/2017 - 4/5/2017 | 150% |
TSS, Inc Common Stock (TSSI) | 2/27/2017 - 4/5/2017 | 149.83% |
Opus Genetics (IRD) | 2/27/2017 - 4/5/2017 | 146.84% |
Ammo (POWW) | 2/27/2017 - 4/5/2017 | 122% |
LifeMD (LFMD) | 2/27/2017 - 4/5/2017 | 120.83% |
Clearpoint Neuro (CLPT) | 2/27/2017 - 4/5/2017 | 110.55% |
Oncolytics Biotech (ONCY) | 2/27/2017 - 4/5/2017 | 104.16% |
Plug Power (PLUG) | 2/27/2017 - 4/5/2017 | 100.89% |
Netcapital (NCPL) | 2/27/2017 - 4/5/2017 | 100% |
Power Solutions International, Inc Common Stock (PSIX) | 2/27/2017 - 4/5/2017 | 94.08% |
InMed Pharmaceuticals (INM) | 2/27/2017 - 4/5/2017 | 91.01% |
Akari Therapeutics (AKTX) | 2/27/2017 - 4/5/2017 | 81.68% |
Riley Exploration Permian (REPX) | 2/27/2017 - 4/5/2017 | 81.03% |
Aurinia Pharmaceuticals (AUPH) | 2/27/2017 - 4/5/2017 | 80.97% |
Lixte Biotechnology (LIXT) | 2/27/2017 - 4/5/2017 | 80% |
BioCryst Pharmaceuticals (BCRX) | 2/27/2017 - 4/5/2017 | 78.81% |
TG Therapeutics (TGTX) | 2/27/2017 - 4/5/2017 | 74.17% |
Cyclacel Pharmaceuticals (CYCC) | 2/27/2017 - 4/5/2017 | 71.28% |
Akoustis Technologies (AKTS) | 2/27/2017 - 4/5/2017 | 67.83% |
Altisource Portfolio Solutions (ASPS) | 2/27/2017 - 4/5/2017 | 64.67% |
Sanara Medtech (SMTI) | 2/27/2017 - 4/5/2017 | 59.02% |
Verastem (VSTM) | 2/27/2017 - 4/5/2017 | 58.97% |
